Related Experiment Video
Updated: Jul 15, 2026

Simultaneous Laryngopharyngeal and Conventional Esophageal pH Monitoring
Published on: December 14, 2020
Utilising multichannel intraluminal impedance for diagnosing GERD: a review
1Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA.
Multichannel intraluminal impedance (MII) detects nonacid reflux, improving gastroesophageal reflux disease (GERD) diagnosis. This technology offers a more comprehensive assessment than traditional pH monitoring alone.
Area of Science:
- Gastroenterology
- Digestive Physiology
- Medical Diagnostics
Background:
- Diagnosing gastroesophageal reflux (GER) can be challenging, particularly for symptoms unresponsive to high-dose acid suppression.
- Advancements in technology enable the detection and quantification of nonacid or weakly acidic reflux.
- Multichannel intraluminal impedance (MII) is an emerging tool for reflux detection.
Purpose of the Study:
- To review the role of MII in diagnosing GERD and related disorders.
- To compare MII with traditional pH monitoring for reflux detection.
- To explore MII's utility in evaluating atypical GERD symptoms.
Main Methods:
- Review of published studies comparing MII and pH monitoring in normal subjects and GERD patients.
- Analysis of MII's ability to detect nonacidic reflux, aerophagia, and differentiate reflux from swallows.
- Examination of studies evaluating MII for atypical GERD symptoms.
Main Results:
- MII detects nonacid or weakly acidic reflux, which occurs frequently in both normal and GERD subjects.
- pH monitoring fails to detect the majority of nonacid or weakly acidic reflux events.
- GERD subjects exhibit more liquid-type reflux, while normal subjects show more gas-type reflux.
- Proton pump inhibitors render reflux nonacidic or weakly acidic without reducing its amount.
Conclusions:
- MII provides a more powerful diagnostic tool for GERD than pH monitoring alone.
- MII enhances the understanding of reflux characteristics, including nonacidic and gas-type reflux.
- MII shows promise in evaluating atypical GERD symptoms and guiding treatment strategies.
Related Concept Videos
Gastroesophageal Reflux Disease II: Clinical Features and Management
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Gastroesophageal Reflux Disease
Gastroesophageal Reflux Disease I: Meaning and Pathophysiology
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Barrett Esophagus-II: Clinical Manifestations and Management
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure entails...
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...

